InspireMD Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for InspireMD, Inc. (NSPR) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-32.01-19.92-18.49-14.92-10.54-9.88-7.24
Depreciation & Amortization0.280.230.190.160.150.000.15
Stock Based Compensation10.144.492.351.580.610.000.00
Change in Working Capital0.74-0.800.40-0.060.48-0.54-0.18
Change in Accounts Receivable0.23-0.770.19-0.750.350.000.00
Change in Inventory-0.46-0.49-0.480.27-0.180.000.00
Change in Accounts Payable0.320.81-0.230.66-0.410.000.00
Change in Other Working Capital0.650.290.92-0.240.720.000.00
Other Operating Activities-0.124.120.010.030.220.49-0.39
Net Cash from Operating Activities-21.87-16.38-15.54-13.21-9.08-9.81-7.61
Investing Activities
Capital Expenditures-1.400.38-0.47-0.34-0.090.28-0.07
Purchases of Investments14.13-40.149.00-22.000.000.000.00
Sales/Maturities of Investments29.00-15.729.00-22.000.000.000.00
Other Investing Activities-0.095.92-0.09-0.11-0.120.000.02
Net Cash from Investing Activities12.64-16.098.44-22.46-0.19-0.39-0.04
Financing Activities
Common Stock Issued18.5337.530.0037.0617.516.3416.38
Other Financing Activities-0.08-4.64-0.14-2.02-1.110.000.00
Net Cash from Financing Activities18.4537.53-0.1435.0316.406.3413.37
Summary
Effect of Forex Changes on Cash0.05-0.06-0.13-0.010.00-0.01-0.05
Net Change in Cash9.285.01-7.37-0.647.13-3.865.72
Cash at Beginning of Period9.644.6312.0012.655.519.383.71
Cash at End of Period18.92-32.474.6312.0012.655.519.38
Free Cash Flow-23.27-16.75-16.02-13.55-9.17-10.09-7.67